TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 312 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q2 2023. The put-call ratio across all filers is 0.21 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $1,024,279 | +6.2% | 79,156 | +13.9% | 0.15% | -3.2% |
| Q1 2024 | $964,883 | +30.0% | 69,466 | +33.6% | 0.16% | +6.0% |
| Q4 2023 | $742,097 | -10.5% | 52,004 | -3.0% | 0.15% | -25.5% |
| Q3 2023 | $829,486 | +8.5% | 53,619 | +10.2% | 0.20% | +3.1% |
| Q2 2023 | $764,543 | +10.1% | 48,666 | +15.5% | 0.19% | -20.2% |
| Q1 2023 | $694,566 | +28.8% | 42,146 | +26.0% | 0.24% | +64.2% |
| Q4 2022 | $539,323 | +34.2% | 33,436 | +8.0% | 0.15% | -9.8% |
| Q3 2022 | $402,000 | -2.7% | 30,959 | +5.3% | 0.16% | -3.0% |
| Q2 2022 | $413,000 | – | 29,388 | – | 0.17% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Y.D. More Investments Ltd | 1,498,811 | $24,700,380 | 5.57% |
| TFG Asset Management GP Ltd | 1,903,662 | $31,372,350 | 4.20% |
| Clean Yield Group | 542,342 | $8,937,796 | 3.81% |
| MANAGED ASSET PORTFOLIOS, LLC | 1,467,952 | $24,192 | 3.67% |
| Mondrian Investment Partners LTD | 4,081,715 | $67,266,663 | 1.48% |
| Sippican Capital Advisors | 82,235 | $1,355,233 | 1.30% |
| Psagot Value Holdings Ltd. / (Israel) | 174,300 | $2,830 | 1.18% |
| Clal Insurance Enterprises Holdings Ltd | 4,365,500 | $71,943 | 1.08% |
| Legacy Wealth Asset Management, LLC | 123,303 | $2,032,033 | 0.73% |
| BRANDES INVESTMENT PARTNERS, LP | 1,817,972 | $29,960,175 | 0.64% |